Table 2 The probability of having a surgical resection of a malign lung tumour, logistic regression for patients diagnosed with lung cancer in 2018–2022 in Norway
From: Distribution and characteristics of malignant tumours by lung lobe
Univariable | Multivariable | |
|---|---|---|
Odds Ratio (95%CI) | Odds Ratio (95%CI) | |
Lobe | ||
RUL | 1.00 | 1.00 |
LUL | 0.98 (0.88–1.09) | 1.01 (0.88–1.16) |
RML | 1.40 (1.17–1.67) | 1.19 (0.93–1.54) |
RLL | 1.22 (1.10–1.36) | 1.21 (1.06–1.41) |
LLL | 1.19 (1.06–1.34) | 1.14 (0.97–1.34) |
p-value | 0.00 | 0.04 |
Sex | ||
Female | 1.00 | 1.00 |
Male | 0.84 (0.78–0.90) | 1.08 (0.98–1.20) |
p-value | 0.00 | 0.13 |
Age | 0.96 (0.95–0.96) | 0.92 (0.92–0.93) |
p-value | 0.00 | 0.00 |
cTNM | ||
I | 1.00 | 1.00 |
II | 0.91 (0.80–1.04) | 1.15 (0.99–1.33) |
III | 0.13 (0.12–0.15) | 0.14 (0.12–0.16) |
IV | 0.01 (0.01–0.01) | 0.01 (0.01–0.01) |
p-value | 0.00 | 0.00 |
Histology | ||
AC | 1.00 | 1.00 |
SCC | 0.79 (0.72–0.87) | 0.66 (0.58–0.74) |
NSCLC, NOS | 0.11 (0.08–0.15) | 0.17 (0.11–0.24) |
Large-cell | 1.24 (0.91–1.70) | 2.10 (1.32–3.35) |
SCLC | 0.06 (0.04–0.08) | 0.14 (0.11–0.20) |
Carcinoid | 6,36 (4.96–8.16) | 1.57 (1.16–2.12) |
Other | 2.03 (1.60–2.58) | 2.49 (1.72–3.59) |
p-value | 0.00 | 0.00 |
EGFR | ||
Not tested | 1.58 (1.22–2.05) | |
Positive | 1.00 | |
Negative | 3.01 (2.51–3.62) | |
p-value | 0.00 |